LOTUSDEV vs PPLPHARMA: Stock Comparison
Head-to-head financial and trading comparison between Sri Lotus Developers and Realty Limited (LOTUSDEV) and Piramal Pharma Limited (PPLPHARMA) in the Cross-Sector Peers sector.
LOTUSDEV
NSE: LOTUSDEVPPLPHARMA
NSE: PPLPHARMAKey Metrics Comparison Table
| Metric | LOTUSDEV | PPLPHARMA | Edge / Winner |
|---|---|---|---|
| Current Market Price (CMP) | ₹176.54 | ₹196.88 | — |
| 1-Year Price Return | +21.52% | +32.32% | PPLPHARMA (10.80% higher) |
| 52-Week High | ₹200.12 | ₹226.62 | — |
| 52-Week Low | ₹129.27 | ₹148.79 | — |
| 30-Day Annualized Volatility | 51.08% | 32.84% | PPLPHARMA (Steadier) |
| 30-Day Average Daily Volume | 3,959,983 | 3,775,308 | LOTUSDEV (Higher Liquidity) |
| Statutory Cost to Trade ₹1 Lakh | ₹118.50 | ₹118.50 | Identical statutory tariff |
Frequently Asked Questions
Between LOTUSDEV and PPLPHARMA, which stock gave better returns over the last year?
PPLPHARMA has outperformed LOTUSDEV over the past 12 months with a gain of 32.32% compared to 21.52%.
Which stock is less volatile: LOTUSDEV or PPLPHARMA?
PPLPHARMA demonstrated lower price volatility (32.84% annualized) compared to LOTUSDEV (51.08%). Lower volatility generally indicates steadier price action during market downturns.
What is the statutory cost to buy ₹1,00,000 of LOTUSDEV vs PPLPHARMA?
Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).
Are LOTUSDEV and PPLPHARMA direct sector competitors?
Yes, both companies operate within the Cross-Sector Peers sector in India and are actively tracked as sector peers by institutional and retail market participants.